Abstract | AIM: METHODS: RESULTS: CONCLUSION: Patients receiving ergocalciferol had lower plasma levels of vascular adhesion molecules despite equivalent use of activated vitamin D therapy. Future investigations should confirm the role of nutritional vitamin D therapy, in addition to activated D therapy, in haemodialysis patients and the potential vascular benefits of these agents.
|
Authors | Magdalene M Assimon, Page V Salenger, Hassan A N El-Fawal, Darius L Mason |
Journal | Nephrology (Carlton, Vic.)
(Nephrology (Carlton))
Vol. 17
Issue 3
Pg. 237-42
(Mar 2012)
ISSN: 1440-1797 [Electronic] Australia |
PMID | 22181351
(Publication Type: Journal Article)
|
Copyright | © 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology. |
Chemical References |
- Ergocalciferols
- Interleukin-6
- Lipoproteins, LDL
- P-Selectin
- Tumor Necrosis Factor-alpha
- Vascular Cell Adhesion Molecule-1
- Vitamins
- beta 2-Glycoprotein I
- oxidized low density lipoprotein
- Intercellular Adhesion Molecule-1
|
Topics |
- Adult
- Aged
- Dietary Supplements
- Ergocalciferols
(therapeutic use)
- Female
- Humans
- Intercellular Adhesion Molecule-1
(blood)
- Interleukin-6
(blood)
- Lipoproteins, LDL
(blood)
- Male
- Middle Aged
- P-Selectin
(blood)
- Pilot Projects
- Renal Dialysis
- Tumor Necrosis Factor-alpha
(blood)
- Vascular Cell Adhesion Molecule-1
(blood)
- Vitamins
(therapeutic use)
- beta 2-Glycoprotein I
(blood)
|